HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brain fluorodeoxyglucose PET in adrenoleukodystrophy.

AbstractOBJECTIVE:
To investigate the cerebral glucose metabolism in subjects with X-linked adrenoleukodystrophy (X-ALD) by using brain [(18)F]-fluorodeoxyglucose PET (FDG-PET).
METHODS:
Cross-sectional study in which 12 adults with various forms of X-ALD underwent clinical evaluation and brain MRI, followed by brain FDG-PET, neuropsychological assessment, and personality and psychopathology evaluation using the Symptom Checkist-90-Revised (SCL-90-R) and the Millon Clinical Multiaxial Inventory-III (MCMI-III).
RESULTS:
When compared to healthy control subjects (n = 27) by using Statistical Parametric Mapping 8 software, the patients with X-ALD-with or without brain MRI changes-showed a pattern of increased glucose metabolism in frontal lobes and reduced glucose metabolism in cerebellum and temporal lobe areas. On single case analysis by Scenium software, we found a similar pattern, with significant (p < 0.02) correlation between the degree of hypermetabolism in the frontal lobes of each patient and the corresponding X-ALD clinical scores. With respect to personality, we found that patients with X-ALD usually present with an obsessive-compulsive personality disorder on the MCMI-III, with significant (p < 0.05) correlation between glucose uptake in ventral striatum and severity of score on the obsessive-compulsive subscale.
CONCLUSIONS:
We examined cerebral glucose metabolism using FDG-PET in a cohort of patients with X-ALD and provided definite evidence that in X-ALD the analysis of brain glucose metabolism reveals abnormalities independent from morphologic and signal changes detected by MRI and related to clinical severity. Brain FDG-PET may be a useful neuroimaging technique for the characterization of X-ALD and possibly other leukodystrophies.
AuthorsEttore Salsano, Giorgio Marotta, Valentina Manfredi, Anna Rita Giovagnoli, Laura Farina, Mario Savoiardo, Davide Pareyson, Riccardo Benti, Graziella Uziel
JournalNeurology (Neurology) Vol. 83 Issue 11 Pg. 981-9 (Sep 09 2014) ISSN: 1526-632X [Electronic] United States
PMID25098542 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014 American Academy of Neurology.
Chemical References
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Glucose
Topics
  • Adrenoleukodystrophy (diagnostic imaging, metabolism)
  • Adult
  • Brain (diagnostic imaging, metabolism)
  • Brain Mapping (methods)
  • Cross-Sectional Studies
  • Fluorodeoxyglucose F18
  • Glucose (metabolism)
  • Humans
  • Image Processing, Computer-Assisted (methods)
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Personality (physiology)
  • Personality Assessment
  • Positron-Emission Tomography
  • Psychiatric Status Rating Scales
  • Radiopharmaceuticals
  • Software
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: